Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions

Type 1 DiabetesHypoglycemia

Interventions

DRUG

GlucaGen

150 ug or 75\*2 ug glucagon will be administered subcutaneously to the participants before and after exercise.

DRUG

Saline

Saline will be used as placebo before and after exercise.

Trial Locations (1)

Sissel Banner Lundemose, Gentofte Municipality

All Listed Sponsors

lead

Steno Diabetes Center Copenhagen

OTHER

NCT05076292 - Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes | Biotech Hunter | Biotech Hunter